Prevention of Multidrug-Resistant Tuberculosis in Close Contacts. Back to the Future?
Neil W. Schluger
American Journal of Respiratory and Critical Care Medicine · 2020-07
Abstract
The author focuses on data from patients who were exposed with tuberculosis (TB) treated with isoniazid (INH) according to Peruvian national guidelines in Peru Topics discussed include vaccine candidates in phase trials after cases of coronavirus disease (COVID-19), clinical trials examining treatment for latent TB and infectious disease challenge in hospitals
MeSH terms
- Medicine
- Tuberculosis
- Clinical trial
- Isoniazid
- Intensive care medicine
- Coronavirus disease 2019 (COVID-19)
- Disease
- Infectious disease (medical specialty)
- Tuberculosis vaccines
- Virology
- Family medicine
- Mycobacterium tuberculosis